Survivor of rare blood clot after AstraZeneca COVID-19 vaccine recalls ordeal.
Most cases of blood clots occurred within two weeks of the person receiving their first dose, and most of the cases reported in Europe have been in women under 60.
Most cases of blood clots occurred within two weeks of the person receiving their first dose, and most of the cases reported in Europe have been in women under 60.
Denmark this week became the first country to stop using AstraZeneca’s COVID-19 vaccine altogether.
Denmark will cease to administer AstraZeneca's COVID-19 vaccine entirely following its possible link to very rare cases of blood clots.
The U.S. health agencies wrote in a Twitter thread that a pause of the COVID-19 vaccine has been recommended "out of an abundance of caution"
It was the first news of EMA's probe of the J&J vaccine, while AstraZeneca's coronavirus vaccine has been dogged for weeks over possible links to rare blood clots.
Dr. Howard Njoo, Canada's deputy chief public health officer, suggested more guidance could be coming for people under age 55 who received the AstraZeneca vaccine.
The EMA, the World Health Organization and numerous other health authorities have said repeatedly that the AstraZeneca vaccine is safe and effective.
The trial disruption is the latest blow to the AstraZeneca vaccine, once hailed as a milestone in the fight against the COVID-19 pandemic.
The regulator has consistently said the benefits outweigh the risks as it investigates 44 reports of an extremely rare brain clotting ailment.
A 44-year-old man was admitted to a Melbourne hospital with clotting days after receiving the AstraZeneca vaccine, suffering serious thrombosis.
Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the COVID-19 vaccine.
The European WHO head noted that Europe remains the second-most affected region in the world in terms of new COVID-19 infections and deaths.
The European WHO head noted that Europe remains the second-most affected region in the world in terms of new COVID-19 infections and deaths.
The agency says it continues to study reports of new cases as they come in and will provide a further assessment next week.
Under a less stringent export control system in force so far, only one shipment in 381 has been barred from leaving the EU.
Coupled with earlier missteps in reporting data and a recent blood clot scare, experts said the new stumble could cause lasting harm to the shot that is key to global efforts.
Brussels pointed an accusing finger at drugmaker AstraZeneca, claiming the company has been "over-selling its production capacity."
AstraZeneca said its experts did not identify any safety concerns related to the vaccine, including finding no increased risk of rare blood clots identified in Europe.
The Biden administration has come under pressure from allies worldwide to share vaccine, particularly from AstraZeneca.
Figures from the European Centers for Disease Prevention and Control this week show there are about 7 million unused AstraZeneca vaccines across the 27-nation EU.